Rituximab Induces Complete Remission of Proteinuria in a Patient With Minimal Change Disease and No Detectable B Cells

Minimal change disease (MCD) is a common cause of nephrotic syndrome. Treatment with steroids is usually effective, but frequent relapses are therapeutic challenges. The anti-CD20 antibody rituximab has shown promising results for treatment of steroid-sensitive nephrotic syndrome. Since predictive b...

Descripción completa

Detalles Bibliográficos
Autores principales: Webendörfer, Maximilian, Reinhard, Linda, Stahl, Rolf A. K., Wiech, Thorsten, Mittrücker, Hans-Willi, Harendza, Sigrid, Hoxha, Elion
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897659/
https://www.ncbi.nlm.nih.gov/pubmed/33628202
http://dx.doi.org/10.3389/fimmu.2020.586012